[HTML][HTML] Diabetes dyslipidemia

JD Schofield, Y Liu, P Rao-Balakrishna, RA Malik… - Diabetes therapy, 2016 - Springer
Diabetes mellitus is associated with a considerably increased risk of premature
atherosclerotic cardiovascular disease. Intensive glycemic control has essentially failed to …

[HTML][HTML] Liraglutide and cardiovascular outcomes in type 2 diabetes

SP Marso, GH Daniels… - … England Journal of …, 2016 - Mass Medical Soc
Background The cardiovascular effect of liraglutide, a glucagon-like peptide 1 analogue,
when added to standard care in patients with type 2 diabetes, remains unknown. Methods In …

Mortality and cardiovascular disease in type 1 and type 2 diabetes

T Htay, K Soe, A Lopez-Perez, AHA Doan… - Current cardiology …, 2019 - Springer
Abstract Purpose of Review The aims of this review are to summarize recent data on
mortality and cardiovascular disease (CVD) in type 1 and type 2 diabetes and to determine …

Air pollution and the heart: updated evidence from meta-analysis studies

AK Dwivedi, D Vishwakarma, P Dubey… - Current Cardiology …, 2022 - Springer
Abstract Purpose of Review Although environmental exposure such as air pollution is
detrimental to cardiovascular disease (CVD), the effects of different air pollutants on different …

[HTML][HTML] Consensus recommendations on sulfonylurea and sulfonylurea combinations in the management of Type 2 diabetes mellitus–International Task Force

S Kalra, S Bahendeka, R Sahay, S Ghosh… - Indian journal of …, 2018 - journals.lww.com
For decades, sulfonylureas (SUs) have been important drugs in the antidiabetic therapeutic
armamentarium. They have been used as monotherapy as well as combination therapy …

[HTML][HTML] The SGLT2 inhibitor luseogliflozin rapidly normalizes aortic mRNA levels of inflammation-related but not lipid-metabolism-related genes and suppresses …

Y Nakatsu, H Kokubo, B Bumdelger… - International journal of …, 2017 - mdpi.com
Recent clinical studies have revealed the treatment of diabetic patients with sodium glucose
co-transporter2 (SGLT2) inhibitors to reduce the incidence of cardiovascular events. Using …

Associations of glycemic index and glycemic load with cardiovascular disease: updated evidence from meta-analysis and cohort studies

AK Dwivedi, P Dubey, SY Reddy, DJ Clegg - Current cardiology reports, 2022 - Springer
Abstract Purpose of Review Diet and lifestyle patterns are considered major contributory
factors for cardiovascular disease (CVD) and mortality. In particular, consuming a diet higher …

[HTML][HTML] Drug repurposing for glioblastoma and current advances in drug delivery—a comprehensive review of the literature

S Alomari, I Zhang, A Hernandez, CY Kraft, D Raj… - Biomolecules, 2021 - mdpi.com
Glioblastoma (GBM) is the most common primary malignant brain tumor in adults with an
extremely poor prognosis. There is a dire need to develop effective therapeutics to …

Haem oxygenase‐1 up‐regulation by rosiglitazone via ROS‐dependent Nrf2‐antioxidant response elements axis or PPARγ attenuates LPS‐mediated lung …

RL Cho, CC Yang, HC Tseng, LD Hsiao… - British journal of …, 2018 - Wiley Online Library
Background and Purpose Haem oxygenase‐1 (HO‐1) is induced by thiazolidinediones
including rosiglitazone and exerts anti‐inflammatory effects in various models. However, the …

[HTML][HTML] Cardiovascular safety of non-insulin pharmacotherapy for type 2 diabetes

J Xu, R Rajaratnam - Cardiovascular diabetology, 2017 - Springer
Patients with type 2 diabetes mellitus have a twofold increased risk of cardiovascular
mortality compared with non-diabetic individuals. There is a growing awareness that …